Enzymatic mechanisms in corneal ulceration with specific reference to familial dysautonomia: Potential for genetic approaches

Advances in Experimental Medicine and Biology

Volumn 506 A, Issue , 2002, Pages 629-639

  Fini, M Elizabeth ^a   Slaugenhaupt, Susan A ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

CONFERENCE PAPER; CORNEA ULCER; DRY EYE; DYSAUTONOMIA; ENZYME ACTIVITY; ENZYME MECHANISM; EPITHELIZATION; FIBROSIS; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE REPAIR; TRANSGENICS; ULCER HEALING;

EID: 0036940370     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0717-8_89     Document Type: Conference Paper

References (49)

1. Anderson, S.L., R. Coli, I.W. Daly, E.A. Kichula, M.J. Rork, S.A. Volpi, S.A., J. Ekstein, and B.Y. Rubin, Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet. 68:753 (2001).
2. Axelrod, F.B., Familial dysautonomia and other congenital and sensory autonomic neuropathies, in: Cell and Molecular Biology of Neural Development, I.B. Blake, ed., Plenum Press, New York, (1974).
3. Baker, K.S., S.C. Anderson, E.G. Romanowski, R.A. Thoft, and N. SundarRaj, Trigeminal ganglion neurons affect corneal epithelial phenotype. Invest Ophthalmol Vis Sci. 34:137 (1993).
4. Berman, M.B., C.H. Dohlman, Collagenase inhibitors. Arch Ophthalmol. (Paris) 35:95 (1975).
5. Berman, M.B., Collagenase and corneal ulceration, in: Collagenase in Normal and Pathological Connective Tissues. D.E. Wooley and J.M. Evanson, ed., John Wiley, Chichester (1980).
6. Berman, M.B., K. Kenyon, K. Hayashi, and N. L'Hernault, The pathogenesis of epithelial defects and stromal ulceration, in: The Cornea: Transactions of the World Congress on the Cornea Ill. D. Cavanagh, ed., Raven Press, New York (1988).
7. Blumenfeld, A., S.A. Slaugenhaupt, F.B. Axelrod, D.E. Lucente, C. Maayan, C.B. Liebert, L.J.Ozelius, J.A. Trofatter, J.L. Haines, X.O. Breakefield, and J.F. Gusella, Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic analysis. Nat Genet. 4:160 (1993).
8. Blumenfeld, A., S.A. Slaugenhaupt, C.B. Liebert, V. Temper, C. Maayan, S. Gill, D.E. Lucente, M. Idelson, K. MacCormack, M.A. Monahan, J. Mull, M. Leyne, M., Mendillo, T. Schiripo, E. Mishori, E., X.O. Breakefield, F.B. Axelrod, and J.F. Gusella, Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31. Am J Hum Genet. 64:1110 (1999).
9. Brown, P.D., Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer. Ann NY Acad Sci. 732:217 (1994).
10. Brown, P.D., Synthetic inhibitors of matrix metalloproteinases, in: Matrix Metalloproteinases, W.C. Parks and R.P. Mecham, eds., Academic Press, NY (1998).
11. Cavanagh, H.D., and A.M. Colley, The molecular basis of neurotrophic keratitis. Acta Ophthalmol Suppl. 192:115 (1989).
12. Cintron, C., C.L. Kublin, Regeneration of corneal tissue. Dev Biol. 61:346 (1977).
13. Cintron, C., L.C. Hassinger, C.L. Kublin, and D.J. Cannon, Biochemical and ultrastuctural changes in collagen during corneal wound healing. J Ultrastruct Res. 65:13 (1978).
14. Cionni, R.J., C. Katakami, J.B. Labrich, and W.-Y. Kao, Collagen metabolism following corneal laceration in rabbits. Curr Eye Res. 5:549 (1986).
15. Conn, H., M. Berman, K. Kenyon, R. Langer, and J. Gage, Stromal vascularization prevents corneal ulceration. Invest Ophthalmol Vis Sci. 19:362-370 (1980).
16. Dohlman, C.H., H.H. Slansky, P.R. Laibson, M.C. Gnadinger, and J. Rose, . Artificial corneal epithelium in acute alkali burns. Ann Ophthalmol. 357:1 (1969)
17. Dohlman, C.H., The function of the corneal epithelium in health and disease (The Jonas S. Friedenwald Memorial lecture). Invest Ophthalmol Vis Sci. 10:376 (1971).
18. Falanga, V., Venous ulceration. J Dermatol Surg Oncol. 19:764 (1993)/
19. Fini, M.E., and M.T. Girard, Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 31:1779 (1990a).
20. Fini, M.E., and M.T. Girard, The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci. 97(Pt 2):373 (1990b).
21. Fini, M.E., Cui, T.-Y., Mouldovan, A., Grobelny, D., Galardy, R.E., and Fisher, S.J., An inhibitor of corneal epithelial cell gela inase. Invest Ophthalmol Vis Sci. 32:151 (1991).
22. Fini, M.E., W. Parks, W.B. Rinehart, M. Matsubara, M.T. Girard, J.R. Cook, J.A. West-Mays, P.M. Sadow, J.J. Jeffrey R.E. Burgeson, M. Raizman, R. Kreuger, and J. Zieske, Role of matrix metalloproteinases in failure to re-epithelialize following corneal injury. Am J Pathol. 149:1287 (1996).
23. Fini, M.E., J.R. Cook, R. Mohan, and C.E. Brinckerhoff, Regulation of matrix metalloproteinase gene expression, in: Matrix Metalloproteinases, W. Parks, and R. Meacham, eds. Academic Press, NY (1998).
24. Foster, C.S., R.P. Zelt, T. Mai-Phan, and K.R. Kenyon, Immunosuppression and selective inflammatory cell depletion: studies on a guinea pig model of corneal ulceration after alkali burning. Arch Ophthalmol. 100:1820 (1982).
25. Girard, M.T., M. Matsubara, C. Kublin, M. Tessier, C. Cintron, and M.E. Fini, Stromal fibroblasts synthesize collagenase and stromelysin during long-term remodeling of repair tissue. J Cell Sci. 104:1001 (1993).
26. Goldberg, M.F., J.W. Payne, and P.W. Brunt, Ophthalmologic studies of familial dysautonomia. Arch Ophthalmol. 80:733 (1963).
27. Gray, R.D., and C.A. Paterson, Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration. Ann NY Acad Sci. 732:206 (1994).
28. Grillo, H.C., and J. Gross, Collagenolytic activity during mammalian wound repair. Develop Biol. 15:00 (1967).
29. Groos, E.B., Neurotrophic keratitis. In: Cornea Volume II: Clinical Diagnosis and Management. J.H. Krachmer, M.J. Mannis, and E.J. Holland eds., Mosby Yearbook, St. Louis (1997).
30. Gross, J. and C.M. Lapiere, Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl AcadSci USA. 48:1014 (1968).
31. Itoi, M., M. Gnadinger, H. Slasky, H. Freeman, and C. Dohlman, Collagenase in the cornea. Exp Eye Res. 8:369 (1969).
32. Kenyon, K.R. Berman, M., Rose, J., and Gage, J., Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens: evidence for the role of PMNs in collagen degradation. Invest Ophthalmol Vis Sci. 18:570-587
33. Kenyon, K.R., Decision making in the therapy of external eye disease: non-infected corneal ulcers. J Ophthalmol. 89:44 (1982).
34. Kenyon, K.R., Inflammatory mechanisms in corneal ulceration. Trans Am Ophthalmol Soc. 83:610 (1985).
35. Laibson, P.R., Recurrent corneal erosions: diagnosis and management, in: Ophthalmology Annual, RD Reinecke, ed., Raven Press, New York, (1989).
36. Matsubara, M., M.T. Girard, C.L. Kublin, C. Cintron, and M.E. Fini, Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Develop Biol. 147:425 (1991a).
37. Matsubara, M., J. Zieske, and M.E. Fini, Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 32:92 (1991b).
38. Moses, M.A., The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells. 15:180 (1997).
39. Oikarinen, A. M. Kylmaniemi, H. Autio-Harmainen, P. Autio, P., and T. Salo, Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol. 101:205 (1993).
40. Parks, W.C., and U.I. Sires, Matrix metalloproteinases and skin biology. Curr Opin Dermatol. 3:240 (1995).
41. Pfister, R., and N. Burnstein, The alkali burned cornea: I: epithelial and stromal repair. Exp Eye Res. 23:519 (1976).
42. Robertson, P.B., R.B. Ryel, RE. Taylor, K.W. Shyu, and H.M. Fullmer, H.M., Collagenase: localization in polymorphonuclear leukocyte granules in the rabbit. Science. 177:64 (1972).
43. Salo, T., M. Makela, M. Kylmaniemi, H. Autio-Harmainen, and H. Larjava, Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest. 70:176 (1994).
44. Schultz, G.S., S. Strelow, G. A. Stern, N. Chegini, M.B. Grant, R.E. Galardy, D. Grobelny, J.J. Rowsey, K. Stonecipher, V. Parmley, and P.T. Khaw, Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 33:3325 (1992).
45. Sigelman, S., and J.S. Friedenwald, Mitotic and wound-healing activities of the corneal epithelium: effect of sensory denervation. Arch Ophthalmol. 52:46 (1954).
46. Slansky, H.H., M.I. Freeman, and M. Itoi, Collagenolytic activity in bovine corneal epithelium. Arch Ophthalmol. 80:496 (1968).
47. Slaugenhaupt, S.A. Blumenfeld, S.P. Gill, M. Leyne, J. Mull, M.P. Cuajungco, C.B. Liebert, B. Chadwick, M. Idelson, L. Reznik, C.M. Robbins, I. Makalowska, M. J. Brownstein, D. Krappmann, C. Scheidereit, C. Maayan, F.B. Axelrod, and J.F. Gusella, Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet. 68:598 (2001).
48. Wagoner, M., and K. Kenyon, Focal points 1985: clinical modules for ophthalmologists. Vol III Module 7: Diagnosis and treatment of non-infected corneal ulcers.1985)
49. Woessner, J.F., Jr., 1998, The matrix metalloproteinase family, in: Matrix Metalloproteinases, W.C. Parks and R.P. Mecham, eds., Academic Press, NY (1985).